A paradigm for cancer treatment using the retinoblastoma gene in a mouse model

Annals of the New York Academy of Sciences

Volumn 886, Issue , 1999, Pages 12-22

  Nikitin, Alexander Yu ^a   Riley, Daniel J ^b   Lee, Wen Hwa ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PREVENTION; CANCER THERAPY; CARCINOGENESIS; CONFERENCE PAPER; GENE FUNCTION; GENE THERAPY; HUMAN; MOUSE; NONHUMAN; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 0033452585     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb09396.x     Document Type: Conference Paper

References (74)

1. 1. BOVERI, T. 1929. The Origin of Malignant Tumors. Williams & Williams. Baltimore.
2. 2. CHARLES, D.R. & E.M. LUCE-CLAUSEN. 1942. The kinetics of papilloma formation in Benzpyrene-treated mice. Cancer Res. 2: 261-263.
3. 3. WUNDERLICH, V. & M.F. RAJEWSKY. 1995. "Tumour suppressor gene" concept of carcinogenesis. Lancet 345: 1570-1571.
4. 4. KNUDSON, A.G. 1971. Mutation and cancer: Statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA 68: 820-823.
5. 5. COMINGS, D.E. 1973. A general theory of carcinogenesis. Proc. Natl. Acad. Sci. USA 70: 3324-3328.
6. 6. HARRIS, H., O.J. MILLER, G. KLEIN, P. WORST & T. TACHIBANA. 1969. Suppression of malignancy by cell fusion. Nature 223: 363-368.
7. 7. WEISSMAN, B.E., P.J. SAXON, S.R. PASQUALE, G.R. JONES, A.G. GEISER & E.J. STANBRIDGE. 1987. Introduction of a normal human chromosome 11 into a Wilms' tumor cell line controls its tumorigenic expression. Science 236: 175-180.
8. 8. FRIEND, S.H., R. BERNARDS, S. ROGELJ, R.A. WEINBERG, J.M. RAPAPORT & D.M.D. ALBERT. 1986. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643-646.
9. 9. LEE, W.H., R. BOOKSTEIN, F. HONG, L.J. YOUNG, J.Y. SHEW & E.Y. LEE. 1987. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence. Science 235: 1394-1399.
10. 10. FUNG, Y.K., A.L. MURPHREE, A. T'ANG, J. QIAN, S.H. HINRICHS & W.F. BENEDICT. 1987. Structural evidence for the authenticity of the human retinoblastoma gene. Science 236: 1657-1661.
11. 11. HUANG, H.J., J.K. YEE, J.Y. SHEW, P.L. CHEN, R. BOOKSTEIN, T. FRIEDMANN, E.Y.-P. LEE & W.H. LEE. 1988. Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells. Science 242: 1563-1566.
12. 12. PAGLIARO, L.C., D. ANTELMAN, D.E. JOHNSON, T. MACHEMER, E.A. MCCULLOCH, E.J. FREIREICH, S.A. STASS, H.M. SHEPARD, D. MANEVAL & J.U. GUTTERMAN. 1995. Recombinant human retinoblastoma protein inhibits cancer cell growth. Cell Growth Differ. 6: 673-680.
13. 13. BOOKSTEIN, R., J.Y. SHEW, P.L. CHEN, P. SCULLY & W.H. LEE. 1990. Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene. Science 247: 712-715.
14. 14. GOODRICH, D.W., Y. CHEN, P. SCULLY & W.-H. LEE. 1992. Expression of the retinoblastoma gene product in bladder carcinoma cells associates with a low frequency of tumor formation. Cancer Res. 52: 1968-1973.
15. 15. TAKAHASHI, R., T. HASHIMOTO, H.J. XU, S.X. HU, T. MATSUI, T. MIKI, H. BIGO-MARSHALL, S.A. AARONSON & W.F. BENEDICT. 1991. The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc. Natl. Acad. Sci. USA 88: 5257-5261.
16. 16. XU, H.J., Y. ZHOU, J. SEIGNE, G.S. PERNG, M. MIXON, C. ZHANG, J. LI, W.F. BENEDICT & S.X. Hu. 1996. Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein. Cancer Res. 56: 2245-2249.
17. 17. WANG, N.P., H. TO, W.H. LEE & E.Y. LEE. 1993. Tumor suppressor activity of RB and p53 genes in human breast carcinoma cells. Oncogene 8: 279-288.
18. 18. ANTELMAN, D., T. MACHEMER, B.C. HUYGHE, H.M. SHEPARD, D. MANEVAL & D.E. JOHNSON. 1995. Inhibition of tumor cell proliferation in vitro and in vivo by exogenous p110RB, the retinoblastoma tumor suppressor protein. Oncogene 10: 697-704.
19. 19. CHEN, P.-L., Y. CHEN, R. BOOKSTEIN & W.-H. LEE. 1990. Genetic mechanisms of tumor suppression by the human p53 gene. Science 250: 1576-1580.
20. 20. BAKER, S.J., S. MARKOWITZ, E.R. FEARON, J.K. WILLSON & B. VOGELSTEIN. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249: 912-915.
21. 21. CASEY, G., M. LO-HSUEH, M.E. LOPEZ, B. VOGELSTEIN & E.J. STANBRIDGE. 1991. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene 6: 1791-1797.
22. 22. GOYETTE, M.C., K. CHO, C.L. FASCHING, D.B. LEVY, K.W. KINZLER, C. PARASKEVA, B. VOGELSTEIN & E.J. STANBRIDGE. 1992. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell. Biol. 12: 1387-1395.
23. 23. CLARKE, A.R., E.R. MAANDAG, M. VAN ROON, N.M. VAN DER LUGT, M. VAN DER VALK, A. BERNS & H. TE RIELE. 1992. Requirement for a functional Rb-1 gene in murine development. Nature 359: 328-330.
24. 24. JACKS, T., A. FAZELI, E.M. SCHMITT, R.T. BRONSON, M.A. GOODELL & R.A. WEINBERG. 1992. Effects of an Rb mutation in the mouse. Nature 359: 295-300.
25. 25. LEE, E.Y., C.Y. CHANG, N. HU, Y.C. WANG, C.C. LAI, K. HERRUP, W.H. LEE & A. BRADLEY. 1992. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359: 288-294.
26. 26. HU, N., A. GUTSMANN, D.C. HERBERT, A. BRADLEY, W.H. LEE & E.Y. LEE. 1994. Heterozygous Rb-1 delta 20/+mice are predisposed to tumors of the pituitary gland with a nearly complete penetrance. Oncogene 9: 1021-1027.
27. 27. CHANG, C.Y., D.J. RILEY, E.Y. LEE & W.H. LEE. 1993. Quantitative effects of the retinoblastoma gene on mouse development and tissue-specific tumorigenesis. Cell Growth Differ. 4: 1057-1064.
28. 28. HARRISON, D.J., M.L. HOOPER, J.F. ARMSTRONG & A.R. CLARKE. 1995. Effects of heterozygosity for the Rb-1t19neo allele in the mouse. Oncogene 10: 1615-1620.
29. 29. WILLIAMS, B.O., L. REMINGTON, D.M. ALBERT, S. MUKAI, R.T. BRONSON & T. JACKS. 1994. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nature Genet. 7: 480-484.
30. +/- mice. Genes Dev. 10: 1870-1879.
31. 31. WILLIAMS, B.O., E.M. SCHMITT, L. REMINGTON, R.T. BRONSON, D.M. ALBERT, R. WEINBERG & T. JACKS. 1994. Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J. 13: 4251-4259.
32. 32. ROBANUS-MAANDAG, E.C., M. VAN DER VALK, M. VLAAR, C. FELTKAMP, J. O'BRIEN, M. VAN ROON, N. VAN DER LUGT, A. BERNS & H. TE RIELE. 1994. Developmental rescue of an embryonic-lethal mutation in the retinoblastoma gene in chimeric mice. EMBO J. 13: 4260-4268.
33. 33. BIGNON, Y.J., Y. CHEN, C.Y. CHANG, D.J. RILEY, J.J. WINDLE, P.L. MELLON & W.H. LEE. 1993. Expression of a retinoblastoma transgene results in dwarf mice. Genes Dev. 7: 1654-1662.
34. +/- mice. Nature Med. 2: 1316-1321.
35. 35. LAMBERTS, S.W.J. et al. 1982. Adrenocorticotropin-secreting pituitary adenomas originate from the anterior or the intermediate lobe in Cushing's disease: Difference in the regulation of hormone secretion. J. Clin. Endocrinol. Metab. 54: 286-291.
36. 36. YAMASAKI, L., R. BRONSON, B.O. WILLIAMS, N.J. DYSON, E. HARLOW & T. JACKS. 1998. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-) mice. Nature Genet. 18: 360-364.
37. +/- mice. Proc. Natl. Acad. Sci. USA 96: 3916-3921.
38. 38. CRYNS, V.L., A. THOR, H.J. XU, S.X. HU, M.E. WIERMAN, A.L. VICKERY, JR., W.F. BENEDICT & A. ARNOLD. 1994. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N. Engl. J. Med. 330: 757-761.
39. 39. BATES, A.S., W.E. FARRELL, E.J. BICKNELL, A.M. MCNICOL, A.J. TALBOT, J.C. BROOME, C.W. PERRETT, R.V. THAKKER & R.N. CLAYTON. 1997. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. J. Clin. Endocrinol. Metabol. 82: 818-824.
40. 40. PEI, L., S. MELMED, B. SCHEITHAUER, K. KOVACS, W.F. BENEDICT & D. PRAGER. 1995. Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: Evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res. 55: 1613-1616.
41. 41. PEARCE, S.H., D. TRUMP, C. WOODING, M.N. SHEPPARD, R.N. CLAYTON & R.V. THAKKER. 1996. Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic and carcinoid tumours. Clin. Endocrinol. 45: 195-200.
42. 42. YOSHIMOTO, K., H. ENDO, M. TSUYUGUCHI, C. TANAKA, T. KIMURA, H. IWAHANA, G. KATO, T. SANO & M. ITAKURA. 1998. Familial isolated primary hyperparathyroidism with parathyroid carcinomas: clinical and molecular features. Clin. Endocrinol. 48: 67-72.
43. 43. COXON, A.B., J.M. WARD, J. GERADTS, G.A. OTTERSON, M. ZAJAC-KAYE & F.J. KAYE. 1998. RET cooperates with RB/p53 inactivation in a somatic multi-step model for murine thyroid cancer. Oncogene 17: 1625-1628.
44. 44. DAY, M.L., R.G. FOSTER, K.C. DAY, X. ZHAO, P. HUMPHREY, P. SWANSON, A.A. POSTIGO, S.H. ZHANG & D.C. DEAN. 1997. Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway. J. Biol. Chem. 272: 8125-8128.
45. 45. LI, J., S.X. HU, G.S. PERNG, Y. ZHOU, K. XU, C. ZHANG, J. SEIGNE, W.F. BENEDICT & H.J. XU. 1996. Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro. Oncogene 13: 2379-2386.
46. 46. MARTEL, C., F. HARPER, S. CEREGHINI, V. NOE, M. MAREEL & C. CREMISI. 1997. Inactivation of retinoblastoma family proteins by SV40 T antigen results in creation of a hepatocyte growth factor/scatter factor autocrine loop associated with an epithelial-fibroblastoid conversion and invasiveness. Cell Growth Differ. 8: 165-178.
47. 47. VALENTE, P., A. MELCHIORI, M.G. PAGGI, L. MASIELLO, D. RIBATTI, L. SANTI, R. TAKAHASHI, A. ALBINI & D.M. NOONAN. 1996. RB1 oncosuppressor gene over-expression inhibits tumor progression and induces melanogenesis in metastatic melanoma cells. Oncogene 13: 1169-1178.
48. 48. BATSCHE, E., C. MUCHARDT, J. BEHRENS, H.C. HURST & C. CREMISI. 1998. RB and c-Myc activate expression of the E-cadherin gene in epithelial cells through interaction with transcription factor AP-2. Mol. Cell. Biol. 18: 3647-3658.
49. 49. NOWELL, P.C. 1976. The clonal evolution of tumor cell populations. Science 194: 23-28.
50. 50. FIALKOW, P.J. 1974. The origin and development of human tumors studied with cell markers. N. Engl. J. Med. 291: 26-35.
51. 51. FEARON, E.R. & B. VOGELSTEIN. 1990. A genetic model for colorectal tumorigenesis. Cell 61: 759-767.
52. 52. KINZLER, K.W. & B. VOGELSTEIN. 1997. Cancer-susceptibility genes. Gatekeepers and caretakers. Nature 386: 761-763.
53. 53. HAMEL, P.A., R.A. PHILLIPS, M. MUNCASTER & B.L. GALLIE. 1993. Speculations on the roles of RB1 in tissue-specific differentiation, tumor initiation, and tumor progression. FASEB J. 7: 846-854.
54. 54. KNUDSON, A.G. 1993. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. USA 90: 10914-10921.
55. 55. BOOKSTEIN, R. & W.H. LEE. 1991. Molecular genetics of the retinoblastoma suppressor gene. Crit. Rev. Oncogen. 2: 211-227.
56. 56. RILEY, D.J., C.C. LAI, C.Y. CHANG, D. JONES, E.Y. LEE & W.H. LEE. 1994. Susceptibility to tumors induced in mice by ethylnitrosourea is independent of retinoblastoma gene dosage. Cancer Res. 54: 6097-6101.
57. 57. NIKITIN, A.Y., D.J. RILEY & W.H. LEE. 1997. Earlier onset of melanotroph carcinogenesis in mice with inherited mutant paternal allele of the retinoblastoma gene. Cancer Res. 57: 4274-4278.
58. 58. HARVEY, M., H. VOGEL, E.Y. LEE, A. BRADLEY & L.A. DONEHOWER. 1995. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res. 55: 1146-1151.
59. 59. EWALD, D., M. LI, S. EFRAT, G. AUER, R.J. WALL, P.A. FURTH & L. HENNIGHAUSEN. 1996. Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science 273: 1384-1386.
60. 60. LI, S. & L. HUANG. 1997. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther. 4: 891-900.
61. 61. LI, S., M. BRISSON, Y. HE & L. HUANG. 1997. Delivery of a PCR amplified DNA fragment into cells: A model for using synthetic genes for gene therapy. Gene Ther. 4: 449-454.
62. 62. Liu, F., H. Qi, L. Huang & D. Liu. 1997. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther. 4: 517-523.
63. 63. BIGNON, Y.J., J.Y. SHEW, D. RAPPOLEE, S.L. NAYLOR, E.Y. LEE, J. SCHNIER & W.-H. LEE. 1990. A single Cys706 to Phe substitution in the retinoblastoma protein causes the loss of binding to SV40 T antigen. Cell Growth Differ. 1: 647-651.
64. 64. RILEY, D.J., E.Y. LEE & W.H. LEE. 1994. The retinoblastoma protein: more than a tumor suppressor. Annu. Rev. Cell. Biol. 10: 1-29.
65. 65. CHEN, P.L., D.J. RILEY & W.H. LEE. 1995. The retinoblastoma protein as a fundamental mediator of growth and differentiation signals. Crit. Rev. Eukar. Gene Express. 5: 79-95.
66. 66. JACKS, T. & R.A. WEINBERG. 1998. The expanding role of cell cycle regulators. Science 280: 1035-1036.
67. 67. UTOMO, A.R.H., A.Y. NIKITIN & W.-H. LEE. 1999. Temporal, spatial, and cell type-specific control of Cre-mediated DNA recombination in transgenic mice. Nature Biotechnol. In press.
68. 68. STERNBERG, N., D. HAMILTON & R. HOESS. 1981. Bacteriophage P1 site-specific recombination. II. Recombination between loxP and the bacterial chromosome. J. Mol. Biol. 150: 487-507.
69. 69. SAUER, B. & N. HENDERSON. 1988. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. Proc. Natl. Acad. Sci. USA 85: 5166-5170.
70. 70. GU, H., J.D. MARTH, P.C. ORBAN, H. MOSSMANN & K. RAJEWSKY. 1994. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265: 103-106.
71. 71. GOSSEN, M. & H. BUJARD. 1992. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89: 5547-5551.
72. 72. GOSSEN, M., S. FREUNDLIEB, G. BENDER, G. MULLER, W. HILLEN & H. BUJARD. 1995. Transcriptional activation by tetracyclines in mammalian cells. Science 268: 1766-1769.
73. 73. FURTH, P.A., L. ST ONGE , H. BÖGER, P. GRUSS, M. GOSSEN, A. KISTNER, H. BUJARD & L. HENNIGHAUSEN. 1994. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc. Natl. Acad. Sci. USA 91: 9302-9306.
74. 74. KISTNER, A., M. GOSSEN, F. ZIMMERMANN, J. JERECIC, C. ULLMER, H. LUBBERT & H. BUJARD. 1996. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc. Natl. Acad. Sci. USA 93: 10933-10938.